A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers

Journal of Psychiatric Research

Volumn 34, Issue 3, 2000, Pages 239-244

  Jönsson, Erik G ^a   Norton, Nadine ^b   Gustavsson, J Petter ^c   Oreland, Lars ^d   Owen, Michael J ^b   Sedvall, Göran C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SKÖVDE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 HIAA; Cerebrospinal fluid; MHPG); Monoamine metabolites (HVA; Monoamine oxidase A gene

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; HOMOVANILLIC ACID; MONOAMINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; DNA POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; ALLELES; BIOGENIC MONOAMINES; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEX FACTORS;

EID: 0342424722     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(00)00013-3     Document Type: Article

References (37)

1. Diagnostic and statistical manual of mental disorders. 3rd ed. 1987;American Psychiatric Association, Washington DC. revised.
2. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.W., Seeburg P.H., Shih J.C. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;4934-4938.
3. Best N.R., Rees M.P., Barlow D.H., Cowen P.J. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology. 17:1992;87-93.
4. Blennow K., Wallin A., Gottfries C.G., Karlsson I., Månsson J.E., Skoog I., Wikkelsö C., Svennerholm L. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals. Eur. Neuropsychopharmacology. 3:1993;55-61.
5. Cawthon R.M., Printar J.E., Haseltine F.P., Breakefield X.O. Differences in the structure of A and B forms of human monoamine oxidase. Journal of Neurochemistry. 37:1981;363-372.
6. Constantino J.N., Murphy D.L. Monoamine metabolites in 'leftover' newborn human cerebrospinal fluid. A potential resource for biobehavioral research. Psychiatry Research. 65:1996;129-142.
7. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nöthen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., Beckmann H., Bellodi L., Lesch K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics. 8:1999;621-624.
8. Donnelly C.H., Murphy D.L. Substrate and inhibitor-related characteristics of human platelet monoamine oxidase. Biochemical Pharmacology. 26:1977;853-858.
9. Eklundh T., Fernström V., Nordin C. Influence of tapping time and atmospheric pressure on concentrations of monoamine metabolites in the cerebrospinal fluid: a prospective study in female volunteers. Journal of Psychiatric Research. 28:1994;511-517.
10. Fowler C.J., Wiberg Å, Oreland L., Marcusson J., Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxidase. Journal of Neural Transmission. 49:1980;1-20.
11. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 379:1996;733-736.
12. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;14065-14069.
13. Geijer T., Neiman J., Rydberg U., Gyllander A., Jönsson E., Sedvall G., Valverius P., Terenius L. Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. European Archives of Psychiatry and Clinical Neuroscience. 244:1994;26-32.
14. Geracioti T.D. Jr, West S.A., Baker D.G., Hill K.K., Ekhator N.N., Wortman M.D., Keck P.E., Norman A.B. Low CSF concentration of a dopamine metabolite in tobacco smokers. American Journal of Psychiatry. 156:1999;130-132.
15. Grove W.M., Andreasen N. Simultaneous tests of many hypotheses in exploratory research. Journal of Nervous and Mental Disease. 170:1982;3-8.
16. Higley J.D., Thompson W.W., Champoux M., Goldman D., Hasert M.F., Kraemer G.W., Scanlan J.M., Suomi S.J., Linnoila M. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Archives of General Psychiatry. 50:1993;615-623.
17. Jönsson E., Sedvall G., Brené S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.-A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.-A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40:1996;1032-1043.
18. Jönsson E.G., Goldman D., Spurlock G., Gustavsson J.P., Nielsen D.A., Linnoila M., Owen M.J., Sedvall G.C. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms. Relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247:1997;297-302.
19. Kochersperger L.M., Parker E.L., Siciliano M., Darlington G.J., Denney R.M. Assignment of genes for human monoamine oxidases A and B to the X chromosome. Journal of Neuroscience Research. 16:1986;601-616.
20. Lan N.C., Heinzmann C., Gal A, Klisak I., Orth U., Lai E., Grimsby J., Sparkes R.S., Mohandas T., Shih J.C. Human monoamine oxidase A and B genes map to Xp11.23 and are deleted in a patient with Norrie disease. Genomics. 4:1989;552-559.
21. Levy E.R., Powell J.F., Buckle V.J., Hsu Y.P., Brakefield X.O., Craig I.W. Localization of human monoamine oxidase A gene to Xp11.23-11.4 by in situ hybridization: implications for Norrie disease. Genomics. 5:1989;368-370.
22. Major L.F., Murphy D.L., Lipper S., Gordon E. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid. Journal of Neurochemistry. 32:1979;229-231.
23. Nordin C., Eklundh T., Fernström V., Swedin A., Zachau A.C. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers. Journal of Psychiatric Research. 29:1995;133-140.
24. Oxenstierna G., Bergstrand G., Edman G., Flyckt L., Nybäck H., Sedvall G. Increased frequency of abberant CSF circulation in schizophrenic patients compared to healthy volunteers. European Psychiatry. 11:1996;16-20.
25. Oxenstierna G., Edman G., Iselius L., Oreland L., Ross S.B., Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. Journal of Psychiatric Research. 20:1986;19-29.
26. Ozelius L., Hsu Y.P., Bruns G., Powell J.F., Chen S., Weyler W., Utterback M., Zucker D., Haines J., Trofatter J.A., et al. Human monoamine oxidase gene (MAOA): chromosome position (Xp21-Xp11) and DNA polymorphism. Genomics. 3:1988;53-58.
27. Pintar J.E., Barbosa J., Francke U., Castligione C.M., Hawkins M. Jr, Breakefield X.O. Gene for monoamine oxidase type A assigned to the human X chromosome. Journal of Neuroscience. 1:1981;166-175.
28. Potter W.Z., Manji H.K. Catecholamines in depression: an update. Clinical Chemistry. 40:1994;279-287.
29. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics. 103:1998;273-279.
30. Sedvall G., Fyrö B., Gullberg B., Nybäck H., Wiesel F.-A., Wode-Helgodt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. British Journal of Psychiatry. 136:1980;366-374.
31. Stenström A., Hardy J., Oreland L. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. Biochemical Pharmacology. 36:1987;2931-2935.
32. Swahn C.-G., Sandgärde B., Wiesel F.-A., Sedvall G. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology. 48:1976;147-152.
33. Träskman-Bendz L. Depression and suicidal behavior. Thesis. Stockholm: Karolinska Institute, 1980.
34. van Kammen D.P., Antelman S. Impaired noradrenergic transmission in schizophrenia? Life Sciences. 34:1984;1403-1413.
35. van Rossum J.M. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. Brill H., Cole J.O., Deniker P., Hippius H., Bradley P.B. Proceedings of the fifth Collegium Internationale Neuropsychopharmacologicum. 1967;321-329 Excerpta Medica, Amsterdam.
36. Whitaker-Azmitia P.M., Zhang X., Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology. 11:1994;125-132.
37. Woolley D.W., Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proceedings of the National Academy of Sciences of the United States of America. 40:1954;228-231.